NIH-funded research R01 grant

Investigating how cannabis and opioid policies affect chronic pain and overdose rates

Official title: Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose

Funded at New York University School of Medicine · NIH-10523523 · Data updated 2026-11-12

This study looks at how legalizing cannabis and changing prescription rules for opioids affect how doctors manage chronic pain and the risk of overdose, helping patients find safer ways to handle their pain.

More Chronic Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2019
Project endNovember 30, 2025
Funding year2023
Award (this year)$698,514
NIH project number5R01DA045872-05
Project IDNIH-10523523 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from chronic pain who are currently prescribed opioids or benzodiazepines.

Less likely to help

Patients who do not use opioids or benzodiazepines for pain management may not receive direct benefits from this research.

What this research studies

This research examines the impact of cannabis legalization and prescription opioid policies on chronic pain management and opioid overdose rates. It aims to understand how these policies interact and influence prescribing practices, particularly in patients who may also be using benzodiazepines. By analyzing data from various states, the study seeks to identify whether increased access to cannabis can serve as a safer alternative to opioids and reduce the risk of overdose. Patients may benefit from insights into safer pain management options and the effects of policy changes on their treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved pain management strategies and reduced opioid overdose rates for patients.

How similar studies have gone: Previous research has shown promising results regarding the use of cannabis as an alternative to opioids, suggesting that this approach may be effective.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Cerda, Magdalena — New York University School of Medicine
  • Study coordinator: Cerda, Magdalena

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.